Completed NA INTERVENTIONAL 2-arm NCT01106495

Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis (SESA)

Study of the Effect of EECP on Subclinical Atherosclerosis

Sponsor: Sun Yat-sen University

Interventions Enhanced External Counterpulsation (EECP) Simvastatin

Updated 10 times since 2017 Last updated: Oct 29, 2020 Started: May 31, 2010 Primary completion: Oct 31, 2018 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01106495, this NA trial focuses on Atherosclerosis and remains completed. Sponsored by Sun Yat-sen University, it has been updated 10 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
May 2019 — Dec 2020 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 5 earlier versions

Jun 2018 — May 2019 [monthly]

Recruiting NA
May 2017 — Jun 2018 [monthly]

Recruiting NA
Apr 2017 — May 2017 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Feb 2017 — Apr 2017 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China